Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry

Biological Procedures Online

Volumn 12, Issue 1, 2010, Pages 56-88

  Mandal, Nakul ^a   Heegaard, Steffen ^a   Prause, Jan Ulrik ^a   Honoré, Bent ^a   Vorum, Henrik ^a  

^a NONE

Author keywords

2D DIGE; 2D PAGE; Mass spectrometry; Ocular proteomics; Sample preparation

Indexed keywords

EYE PROTEIN;

AQUEOUS HUMOR; CELL VIABILITY; CONJUNCTIVA EPITHELIUM; CORNEA EPITHELIUM; DENSITY GRADIENT; EPITHELIUM CELL; EYE DISEASE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LENS EPITHELIUM; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RETINA NERVE CELL; REVIEW; SCLERA; SENSITIVITY AND SPECIFICITY; TRABECULAR MESHWORK; TWO DIMENSIONAL GEL ELECTROPHORESIS; UVEA MELANOMA; VITREOUS BODY;

EID: 78649831419     PISSN: 14809222     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12575-009-9019-7     Document Type: Review

References (134)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11):844-851
2. Sommer A (2004) Global health, global vision. Arch Ophthalmol 122:911-912
3. Frick KD, Foster A (2003) The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol 135:471-476 (Pubitemid 36315956)
4. Steely HT Jr, Clark AF (2000) The use of proteomics in ophthalmic research. Pharmacogenomics 1:267-280
5. Lam TC, Chun RK, Li KK, To CH (2008) Application of proteomic technology in eye research: a mini review. Clin Exp Optom 91:23-33
6. Collins FS, Green ED, Guttmacher AE, Guyer MS (2003) A vision for the future of genomics research. Nature 422:835-847
7. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921
8. Celera Genomics (2001) The sequence of the human genome. Science 291:1304-1351
9. Pandey A, Mann M (2000) Proteomics to study genes and genomes. Nature 405: 837-846
10. Anderson NG, Matheson A, Anderson NL (2001) Back to the future: the human protein index (HPI) and the agenda for post-proteomic biology. Proteomics 1:3-12
11. Honoré B, Ostergaard M, Vorum H (2004) Functional genomics studied by proteomics. Bioessays 26:901-915
12. de Godoy LM, Olsen JV, Cox J, Nielsen ML, Hubner NC, Fröhlich F, Walther TC, Mann M (2008) Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455(7217):1251-1254
13. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R,Hood L (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292(5518):929-934
14. Graves PR, Haystead TA (2002) Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 66:39-63
15. O'Farrell PH (1975) High resolution twodimensional electrophoresis of proteins. J Biol Chem 250:4007-4021
16. Rabilloud T (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2:3-10
17. Wittmann-Liebold B, Graack HR, Pohl T (2006) Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6:4688-4703
18. Blackstock WP, Weir MP (1999) Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol 17: 121-127
19. Jackson D, Rowlinson RA, Eaton CK, Nickson JA, Wilson ID, Mills JD, Wilkinson RW, Tonge RP (2006) Prostatic tissue protein alterations due to delayed time to freezing. Proteomics 6 (13): 3901-3908
20. Sarto C, Valsecchi C, Mocarelli P (2002) Renal cell carcinoma: handling and treatment. Proteomics 2:1627-1629
21. Cañas B, Piñeiro C, Calvo E, López-Ferrer D, Gallardo JM (2007) Trends in sample preparation for classical and second generation proteomics. J Chromatogr A 1153 (1-2):235-258
22. Tannu NS, Hemby SE (2006) Methods for proteomics in neuroscience. Prog Brain Res 158:41-82
23. López JL (2007) Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B Analyt Technol Biomed Life Sci 849(1-2):190-202
24. Hopkinson A, McIntosh RS, Layfield R, Keyte J, Dua HS, Tighe PJ (2005) Optimised two-dimensional electrophoresis procedures for the protein characterisation of structural tissues. Proteomics 5:1967-1979
25. Braun RJ, Kinkl N, Beer M, Ueffing M (2007) Two-dimensional electrophoresis of membrane proteins. Anal Bioanal Chem 389:1033-1045
26. Distler AM, Kerner J, Hoppel CL (2008) Proteomics of mitochondrial inner and outer membranes. Proteomics 8:4066-4082
27. Rabilloud T, Chevallet M, Luche S, Lelong C (2008) Fully denaturing two-dimensional electrophoresis of membrane proteins: a critical update. Proteomics 8:3965-3973
28. Thompson LJ, Wang F, Proia AD, Peters KG, Jarrold B, Greis KD (2003) Proteome analysis of the rat cornea during angiogenesis. Proteomics 3:2258-2266
29. Scroggs MW, Proia AD, Smith CF, Halperin EC, Klintworth GK (1991) The effect of total-body irradiation on corneal neovascularization in the Fischer 344 rat after chemical cauterization. Invest Ophthalmol Vis Sci 32:2105-2111
30. Nielsen K, Vorum H, Fagerholm P, Birkenkamp-Demtröder K, Honoré B, Ehlers N, Orntoft TF (2006) Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study. Exp Eye Res 82(2):201-209
31. Nielsen K, Birkenkamp-Demtroder K, Ehlers N, Orntoft TF (2003) Identification of differentially expressed genes in keratoconus epithelium analyzed on microarrays. Invest Ophthalmol Vis Sci 44:2466-2476
32. Jurkunas UV, Bitar MS, Rawe I, Harris DL, Colby K, Joyce NC (2008) Increased clusterin expression in Fuchs' endothelial dystrophy. Invest Ophthalmol Vis Sci 49: 2946-2955
33. Karring H, Thogersen IB, Klintworth GK, Moller-Pedersen T, Enghild JJ (2005) A dataset of human cornea proteins identified by Peptide mass fingerprinting and tandem mass spectrometry. Mol Cell Proteomics 4:1406-1408
34. Shimmura S, Miyashita H, Higa K, Yoshida S, Shimazaki J, Tsubota K (2006) Proteomic analysis of soluble factors secreted by limbal fibroblasts. Mol Vis 12:478-484
35. Patel N, Solanki E, Picciani R, Cavett V, Caldwell-Busby JA, Bhattacharya SK (2008) Strategies to recover proteins from ocular tissues for proteomics. Proteomics 8:1055-1070
36. Lu F, Zhou X, Xie R, Wu Y, Hu Y, Zhang L, Li H, Mao X, Hu D, Qu J (2007) Fea-sibility of two-dimensional gel electropho-resis used for proteomic analysis of human scleral fibroblasts. Curr Eye Res 32 (4):319-329
37. Zhang Y, Gao Q, Duan S, He Y, Sun X, Jiang R, Duan Y, Zhong X, Ge J (2008) Upregula-tion of Copine1 in trabecular meshwork cells ofPOAG patients: a membrane proteomics approach. MolVis 14:1028-1036
38. Shinzato M, Yamashiro Y, Miyara N, Iwamatsu A, Takeuchi K, Umikawa M, Bayarjargal M, Kariya K, Sawaguchi S (2007) Proteomic analysis of the trabecular meshwork ofrats in a steroid-induced ocular hypertension model: downregulation of type I collagen C-propeptides. Ophthalmic Res 39(6):330-337
39. Steely HT, Dillow GW, Bian L, Grundstad J, Braun TA, Casavant TL, McCartney MD, Clark AF (2006) Protein expression in a transformed trabecular meshwork cell line: proteome analysis. Mol Vis 12:372-383
40. Picciani R, Junk AK, Bhattacharya SK (2008) Technical Brief: a novel strategy for enrichment of trabecular meshwork protease proteome. Mol Vis 14:871-877
41. Zhao X, Ramsey KE, Stephan DA, Russell P (2004) Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth fac-tor-beta. Invest Ophthalmol Vis Sci 45: 4023-4034
42. Funding M, Vorum H, Honoré B, Nexo E, Ehlers N (2005) Proteomic analysis ofaqueous humour from patients with acute corneal rejection. Acta Ophthalmol Scand 83:31-39 (Pubitemid 40326418)
43. Duan X, Lu Q, Xue P, Zhang H, Dong Z, Yang F, Wang N (2008) Proteomic analysis of aqueous humor from patients with myo-pia. MolVis 14:370-377
44. Grus FH, Joachim SC, Sandmann S, Thiel U, Bruns K, Lackner KJ, Pfeiffer N (2008) Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 14:1437-1445
45. Herber S, Grus FH, Sabuncuo P, Augustin AJ (2001) Two-dimensional analysis oftear protein patterns ofdiabetic patients. Elec-trophoresis 22:1838-1844
46. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B (2002) Incidence ofuveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci 43:2579-2583
47. Damato B (2006) Treatmentofprimaryintra-ocular melanoma. Expert Rev Anticancer Ther 6:493-506
48. Pardo M, Garcia A, Thomas B, Piñeiro A, Akoulitchev A, Dwek RA, Zitzmann N (2005) Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics 5(18):4980-4993
49. Zuidervaart W, Hensbergen PJ, Wong MC et al (2006) Proteomic analysis ofuveal melanoma reveals novel potential markers involved in tumor progression. Invest Oph-thalmol Vis Sci 47:786-793
50. Coupland SE, Vorum H, Mandal N, Kalirai H, Honoré B, Urbak SF, Lake SL, Dopierala J, Damato BE (2010) Proteomics ofuveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci 51 (1):12-20
51. Andley UP (2007) Crystallins in the eye: function and pathology. Prog Retin Eye Res 26:78-98
52. Hoehenwarter W, Klose J, Jungblut PR (2006) Eye lens proteomics. Amino Acids 30:369-389
53. Bhat SP (2004) Transparency and non-refractive functions of crystallins\a pro-posal. Exp Eye Res 79:809-816
54. Wilmarth PA, Taube JR, Riviere MA, Duncan MK, David LL (2004) Proteomic and sequence analysis of chicken lens crys-tallins reveals alternate splicing and trans-lational forms of beta B2 and beta A2 crystallins. Invest Ophthalmol Vis Sci 45:2705-2715
55. Harrington V, Srivastava OP, Kirk M (2007) Proteomic analysis of water insoluble pro-teins from normal and cataractous human lenses. MolVis 13:1680-1694
56. Posner M, Hawke M, Lacava C, Prince CJ, Bellanco NR, Corbin RW (2008) A proteome map of the zebrafish (Danio rerio) lens reveals similarities between zebrafish and mammalian crystallin expres-sion. MolVis 14:806-814
57. Bahk SC, Lee SH, Jang JU, Choi CU, Lee BS, Chae SC, Song HJ, Park ZY, Yang YS, Chung HT (2006) Identification ofcrystal-lin family proteins in vitreous body in rat endotoxin-induced uveitis: involvement of crystallin truncation in uveitis pathogenesis. Proteomics 6(11):3436-3444
58. Deeg CA, Altmann F, Hauck SM, Schoeffmann S, Amann B, Stangassinger M, Ueffing M (2007) Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics (9):1540-1548
59. Nakanishi T, Koyama R, Ikeda T, Shimizu A (2002) Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. J Chromatogr B Analyt Technol Biomed Life Sci 776:89-100
60. Yamane K, Minamoto A, Yamashita H, Takamura H, Miyamoto-Myoken Y, Yoshizato K, Nabetani T, Tsugita A, Mishima HK (2003) Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2(11):1177-1187
61. Ouchi M, West K, Crabb JW, Kinoshita S, Kamei M (2005) Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res 81:176-182
62. Kim T, Kim SJ, Kim K, Kang UB, Lee C, Park KS, Yu HG, Kim Y (2007) Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics 7(22):4203-4215
63. Ulrich JN, Spannagl M, Kampik A,Gandorfer A (2008) Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders. Clin Experiment Ophthalmol 36:431-436
64. Neal RE, Bettelheim FA, Lin C, Winn KC, Garland DL, Zigler JS Jr (2005) Alterations in human vitreous humour following cataract extraction. Exp Eye Res 80:337-347
65. Liu T, Qian WJ, Mottaz HM, Gritsenko MA, Norbeck AD, Moore RJ, Purvine SO, Camp DG 2nd, Smith RD (2006) Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol Cell Proteomics 5 (11):2167-2174
66. Quin GG, Len AC, Billson FA, Gillies MC (2007) Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 7:2636-2650
67. Wang YD, Wu JD, Jiang ZL, Wang YB, Wang XH, Liu C, Tong MQ (2007) Comparative proteome analysis of neural retinas from type 2 diabetic rats by two-dimensional electrophoresis. Curr Eye Res 32 (10):891-901
68. Fort PE, Freeman WM, Losiewicz MK, Singh RS, Gardner TW (2009) The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin. Mol Cell Proteomics 8:767-779
69. Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA (2006) The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2280-2290
70. Vorum H, Ostergaard M, Rice GE, Honoré B, Bek T (2007) Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis\a proteomic study. Proteome Sci 5:5
71. Nordgaard CL, Berg KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA (2006) Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 47(3):815-822
72. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA (2008) Mitochondrial proteomics of the retinal pigment epitheliumat progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci 49:2848-2855
73. Shibuya M, Okamoto H, Nozawa T, Utsumi J, Reddy VN, Echizen H, Tanaka Y, Iwata T (2007) Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2. Invest Ophthalmol Vis Sci 48(2):516-521
74. Schacke W, Beck KF, Pfeilschifter J, Hattenbach LO (2007) Expression of ubiquitin carboxy-terminal hydrolase-l1 in photocoagulated human retinal pigment epithelial cells. Curr Eye Res 32:367-372
75. Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M (2006) Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res 5:862-878
76. West KA, Yan L, Shadrach K, Sun J, Hasan A, Miyagi M, Crabb JS, Hollyfield JG, Marmorstein AD, Crabb JW (2003) Protein database, human retinal pigment epithelium. Mol Cell Proteomics 2(1):37-49
77. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99(23):14682-14687 (Pubitemid 35334544)
78. Umeda S, Suzuki MT, Okamoto H, Ono F, Mizota A, Terao K, Yoshikawa Y, Tanaka Y, Iwata T (2005) Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms ofmacular degeneration in cynomol-gus monkey (Macaca fascicularis). FASEB J 19(12):1683-1685
79. Chevalier F, Rofidal V, Vanova P, Bergoin A, Rossignol M (2004) Proteomic capacity ofrecent fluorescent dyes for protein stain-ing. Phytochemistry 65:1499-1506
80. Harris LR, Churchward MA, Butt RH, Coorssen JR (2007) Assessing detection methods for gel-based proteomic analyses. J Proteome Res 6:1418-1425
81. Smejkal GB (2004) The Coomassie chronicles: past, present and future perspectives in poly-acrylamide gel staining. Expert Rev Proteomics 1:381-387
82. NeuhoffV, Arold N, Taube D, Ehrhardt W (1988) Improved staining ofproteins in poly-acrylamide gels including isoelectric focusing gels with clear background at nanogram sen-sitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9:255-262
83. Chevallet M, Luche S, Rabilloud T (2006) Silver staining ofproteins in polyacrylamide gels. Nat Protoc 1:1852-1858
84. Miller I, Crawford J, Gianazza E (2006) Protein stains for proteomic applications: which, when, why? Proteomics 6:5385-5408
85. Luo S, Wehr NB, Levine RL (2006) Quan-titation of protein on gels and blots by in-frared fluorescence of Coomassie blue and Fast Green. Anal Biochem 350:233-238
86. Lopez MF, Berggren K, Chernokalskaya E, Lazarev A, Robinson M, Patton WF (2000) A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to pro-tein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis 21:3673-3683
87. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858
88. Lopez MF (2000) Better approaches to finding the needle in a haystack: optimizing proteome analysis through automation. Electrophoresis 21:1082-1093
89. Mortz E, Krogh TN, Vorum H, Görg A (2001) Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time offlight analysis. Proteomics 1 (11):1359-1363
90. Winkler C, Denker K, Wortelkamp S, Sickmann A (2007) Silver-and Coomassie-staining protocols: detection limits and compatibilitywith ESI MS. Electrophoresis 28: 2095-2099
91. Lin JF, Chen QX, Tian HY, Gao X, Yu ML, Xu GJ, Zhao FK (2008) Stain efficiency and MALDI-TOF MS compatibility ofsev-en visible staining procedures. Anal Bioanal Chem 390(7):1765-1773
92. Chevallet M, Diemer H, Luche S, van Dorsselaer A, Rabilloud T, Leize-Wagner E (2006) Improved mass spectrometry compatibility is afforded by ammoniacal silver staining. Proteomics 6:2350-2354
93. Dutt MJ, Lee KH (2000) Proteomic analysis. Curr Opin Biotechnol 11:176-179
94. Chevallet M, Luche S, Diemer H, Strub JM, Van Dorsselaer A, Rabilloud T (2008) Sweet silver: a formaldehyde-free silver staining using aldoses as developing agents, with enhanced compatibility with mass spectrometry. Proteomics 8:4853-4861
95. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Rghetti PG (2004) Blue silver: a very sensitive colloidal Coo-massie G-250 staining for proteome analy-sis. Electrophoresis 25(9):1327-1333
96. Nishihara JC, Champion KM (2002) Quantitative evaluation of proteins in one-and two-dimensional polyacrylamide gels using a fluorescent stain. Electropho-resis 23:2203-2215
97. Berggren K, Chernokalskaya E, Steinberg TH, Kemper C, Lopez MF, Diwu Z, Haugland RP, Patton WF (2000) Back-ground-free, high sensitivity staining of proteins in one-and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21(12): 2509-2521
98. Mackintosh JA, Choi HY, Bae SH, Veal DA, Bell PJ, Ferrari BC, Van Dyk DD, Verrills NM, PaikYK, Karuso P (2003) Afluorescent natural product for ultra sensitive detection of proteins in one-dimensional and two-dimensional gel electrophoresis. Proteomics 3(12):2273-2288
99. Smejkal GB, Robinson MH, Lazarev A (2004) Comparison offluorescent stains: relative photostability and differential stain-ing ofproteins in two-dimensional gels. Electrophoresis 25:2511-2519
100. Unlü M, Morgan ME, Minden JS (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18(11):2071-2077
101. Viswanathan S, Unlü M, Minden JS (2006) Two-dimensional difference gel electropho-resis. Nat Protoc 1(3):1351-1358
102. Timms JF, Cramer R (2008) Difference gel electrophoresis. Proteomics 8:4886-4897
103. Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669-678
104. Hannigan A, Burchmore R, Wilson JB (2007) The optimization of protocols for proteome difference gel electrophore-sis (DiGE) analysis ofpreneoplastic skin. J Proteome Res 6:3422-3432
105. Wheelock AM, Goto S (2006) Effects of post-electrophoretic analysis on variance in gel-based proteomics. Expert Rev Pro-teomics 3:129-142
106. Minden JS, Dowd SR, Meyer HE, Stuhler K (2009) Difference gel electrophoresis. Electrophoresis 30(Suppl 1):S156-161
107. Tannu NS, Hemby SE (2006) Two-dimensional fluorescence difference gel electrophoresis for comparative proteo-mics profiling. Nat Protoc 1:1732-1742
108. García-Ramírez M, Canals F, Hernández C, Colomé N, Ferrer C, Carrasco E, García-Arumí J, Simó R (2007) Proteo-mic analysis of human vitreous fluid by fluorescence-based difference gel electro-phoresis (DIGE): a new strategy for identi-fying potential candidates in the pathogenesis ofproliferative diabetic reti-nopathy. Diabetologia 50(6):1294-1303
109. Lam TC, Li KK, Lo SC, Guggenheim JA, To CH (2007) Application of fluo-rescence difference gel electrophoresis technology in searching for protein bio-markers in chick myopia. J Proteome Res 6:4135-4149
110. Zamora DO, Rviere M, Choi D, Pan Y, Planck SR, Rosenbaum JT, David LL, Smith JR (2007) Proteomic profiling of hu-man retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue oforigin. MolVis 13:2058-2065
111. Zipplies JK, Hauck SM, Schoeffmann S, Amann B, Stangassinger M, Ueffing M, Deeg CA (2009) Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. J Pro-teome Res 8(2):992-998
112. Raman B, Cheung A, Marten MR (2002) Quantitative comparison and evaluation of two commercially available, two-dimensional electrophoresis image analysis software packages, Z3 and Melanie. Electrophoresis 23: 2194-2202
113. Rosengren AT, Salmi JM, Aittokallio T, Westerholm J, Lahesmaa R, Nyman TA, Nevalainen OS (2003) Comparison of PDQuest and Progenesis software pack-ages in the analysis of two-dimensional electrophoresis gels. Proteomics 3 (10):1936-1946
114. Arora PS, Yamagiwa H, Srivastava A, Bolander ME, Sarkar G (2005) Compar-ative evaluation of two two-dimensional gel electrophoresis image analysis soft-ware applications using synovial fluids from patients with joint disease. J Orthop Sci 10:160-166
115. Wheelock AM, Buckpitt AR (2005) Software-induced variance in two-dimensional gel electrophoresis image analysis. Electrophoresis 26:4508-4520
116. Shively JE (2000) The chemistry ofpro-tein sequence analysis. EXS 88:99-117
117. Aebersold R, Mann M (2003) Mass spec-trometry-based proteomics. Nature 422: 198-207
118. Reinders J, Lewandrowski U, Moebius J, Wagner Y, Sickmann A (2004) Challenges in mass spectrometry-based proteomics. Proteomics 4:3686-3703
119. Cravatt BF, Simon GM, Yates JR 3rd (2007) The biological impact ofmass-spectrometry-based proteomics. Nature 450:991-1000
120. Cañas B, López-Ferrer D, Ramos-Fernández A, Camafeita E, Calvo E (2006) Mass spectrometry technologies for proteomics. Brief Funct Genomic Proteomic 4(4):295-320
121. Chait BT (2006) Chemistry. Mass spec-trometry: bottom-up or top-down? Sci-ence 314:65-66
122. Washburn MP, Wolters D, Yates JR 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242-247 (Pubitemid 32220565)
123. Gygi SP, Rst B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantita-tive analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999
124. Allison WT, Veldhoen KM, Hawryshyn CW (2006) Proteomic analysis ofopsins and thyroid hormone-induced retinal de-velopment using isotope-coded affinity tags (ICAT) and mass spectrometry. Mol Vis 12:655-672
125. Unwin RD, Pierce A, Watson RB, Sternberg DW,WhettonAD (2005) Quantitative pro-teomic analysis using isobaric protein tags enables rapid comparison ofchanges in tran-script and protein levels in transformed cells. Mol Cell Proteomics 4:924-935
126. Zhou L, Beuerman RW, Huang L, Barathi A, Foo YH, Li SF, Chew FT, Tan D (2007) Proteomic analysis of rabbit tear flu-id: Defensin levels after an experimental cor-neal wound are correlated to wound closure. Proteomics 7(17):3194-3206
127. Zhou L, Beuerman RW, Chan CM, Zhao SZ, Li XR, Yang H, Tong L, Liu S, Stern ME, Tan D (2009) Identification oftear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 8(11):4889-4905
128. Mann M (2006) Functional and quantita-tive proteomics using SILAC Nat Rev Mol Cell Biol 7:952-958
129. An E, Lu X, Flippin J, Devaney JM, Halligan B, Hoffman EP, Strunnikova N, Csaky K, Hathout Y (2006) Secreted proteome profiling in human RPE cell cultures derived from donors with age re-lated macular degeneration and age matched healthy donors. J Proteome Res 5(10):2599-2610
130. Choe LH, Aggarwal K, Franck Z, Lee KH (2005) A comparison of the consistency of proteome quantitation using two-dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells. Electrophoresis 26:2437-2449
131. Gagné JP, Ethier C, Gagné P, Mercier G, Bonicalzi ME, Mes-Masson AM, Droit A, Winstall E, Isabelle M, Poirier GG (2007) Comparative proteome analysis of human epithelial ovarian cancer. Proteome Sci 5:16
132. Wu WW, Wang G, Baek SJ, Shen RF (2006) Comparative study ofthree proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel-or LC-MALDI TOF/TOF. J Proteome Res 5:651-658
133. Bindschedler LV, Palmblad M, Cramer R (2008) Hydroponic isotope labelling of entire plants (HILEP) for quantitative plant proteomics; an oxidative stress case study. Phytochemistry 69:1962-1972
134. Honoré B(2001) Genome-and proteome-based technologies: status and applications in the postgenomic era. Expert Rev Mol Diagn 1(3):265-274